ScholarIQanswers from OpenAlex & ORCID
Clifford A. Hudis
ResearcherPublications, citations & collaboration network
Clifford A. Hudis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Clifford A. Hudis have?
ScholarIQindexed works
Clifford A. Hudis has 934 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Clifford A. Hudis have?
ScholarIQcitation count
Clifford A. Hudis has 82,579 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Clifford A. Hudis?
ScholarIQh-index
Clifford A. Hudis has an h-index of 128 in OpenAlex.
What is the i10-index of Clifford A. Hudis?
ScholarIQi10-index
Clifford A. Hudis has an i10-index of 434 in OpenAlex.
What is the ORCID of Clifford A. Hudis?
ScholarIQorcid
The ORCID for Clifford A. Hudis is on the source record.
What is the OpenAlex record for Clifford A. Hudis?
ScholarIQopenalex
The OpenAlex for Clifford A. Hudis is on the source record.
What are the most-cited papers on Clifford A. Hudis?
ScholarIQmost cited works
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Ethan Basch, Allison M. Deal, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren J. Rogak, Antonia V. Bennett, Amylou C. Dueck, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Allison Barz Leahy, Paul J. Novotny, M. Fruscione, Jeff A. Sloan, Deborah Schrag
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Clifford A. Hudis
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
Ethan Basch, Allison M. Deal, Amylou C. Dueck, Howard I. Scher, Mark G. Kris, Clifford A. Hudis, Deborah Schrag
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Fátima Cardoso, A. Costa, Elżbieta Senkus, Matti Aapro, Fabrice André, Carlos H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Maria João Cardoso, L. Carey, D. Corneliussen-James, Giuseppe Curigliano, Véronique Dièras, N. El Saghir, Alexandru Eniu, Lesley Fallowfield, D. Fenech, Prudence A. Francis, Karen A. Gelmon, Alessandra Gennari, Nadia Harbeck, Clifford A. Hudis, Bella Kaufman, Ian E. Krop, Musa Mayer, Hanneke Meijer, Shirley Mertz, Shinji Ohno, Olivia Pagani, Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer